Literature DB >> 15539502

Antigenic determinants of alpha-like proteins of Streptococcus agalactiae.

Johan A Maeland1, Lars Bevanger, Randi Valsoe Lyng.   

Abstract

The majority of group B streptococcus (GBS) isolates express one or more of a family of surface-anchored proteins that vary by strain and that form ladder-like patterns on Western blotting due to large repeat units. These proteins, which are important as GBS serotype markers and as inducers of protective antibodies, include the alpha C (Calpha) and R4 proteins and the recently described alpha-like protein 2 (Alp2), encoded by alp2, and Alp3, encoded by alp3. In this study, we examined antigenic determinants possessed by Alp2 and Alp3 by testing of antibodies raised in rabbits, mainly by using enzyme-linked immunosorbent assays (ELISA) and an ELISA absorption test. The results showed that Alp2 and Alp3 shared an antigenic determinant, which may be a unique immunological marker of the Alp variants of GBS proteins. Alp2, in addition, possessed an antigenic determinant which showed specificity for Alp2 and a third determinant which showed serological cross-reactivity with Calpha. Alp3, in addition to the determinant common to Alp2 and Alp3, harbored an antigenic site which also was present in the R4 protein, whereas no Alp3-specific antigenic site was detected. These ELISA-based results were confirmed by Western blotting and a fluorescent-antibody test. The results are consistent with highly complex antigenic structures of the alpha-like proteins in a fashion which is in agreement with the recently described structural mosaicism of the alp2 and alp3 genes. The results are expected to influence GBS serotyping, immunoprotection studies, and GBS vaccine developments.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15539502      PMCID: PMC524766          DOI: 10.1128/CDLI.11.6.1035-1039.2004

Source DB:  PubMed          Journal:  Clin Diagn Lab Immunol        ISSN: 1071-412X


  25 in total

1.  Distribution and expression of bca, the gene encoding the c alpha protein, by Streptococcus agalactiae.

Authors:  J A Maeland; O G Brakstad; L Bevanger; S Krokstad
Journal:  J Med Microbiol       Date:  2000-02       Impact factor: 2.472

2.  The putative R1 protein of Streptococcus agalactiae as serotype marker and target of protective antibodies.

Authors:  S R Moyo; J A Maeland; R V Lyng
Journal:  APMIS       Date:  2001-12       Impact factor: 3.205

3.  Complete and incomplete Ibc protein fraction in group B streptococci.

Authors:  L Bevanger; J A Maeland
Journal:  Acta Pathol Microbiol Scand B       Date:  1979-02

4.  Molecular profiles of group B streptococcal surface protein antigen genes: relationship to molecular serotypes.

Authors:  Fanrong Kong; Sonia Gowan; Diana Martin; Gregory James; Gwendolyn L Gilbert
Journal:  J Clin Microbiol       Date:  2002-02       Impact factor: 5.948

5.  Type classification of group B streptococci by the fluorescent antibody test.

Authors:  L Bevanger; J A Maeland
Journal:  Acta Pathol Microbiol Scand B       Date:  1977-12

6.  Antibodies against Streptococcus agalactiae proteins c(alpha) and R4 in sera from pregnant women from Norway and Zimbabwe.

Authors:  S R Moyo; J A Maeland; J Mudzori
Journal:  Clin Diagn Lab Immunol       Date:  2001-11

7.  Antibodies raised in animals against the Streptococcus agalactiae proteins c alpha and R4 and normal human serum antibodies target distinct epitopes.

Authors:  Sylvester R Moyo; Johan A Maeland
Journal:  J Med Microbiol       Date:  2003-05       Impact factor: 2.472

8.  Typing of human isolates of Streptococcus agalactiae (group B streptococcus, GBS) strains from Zimbabwe.

Authors:  Sylvester R Moyo; Johan A Maeland; Kåre Bergh
Journal:  J Med Microbiol       Date:  2002-07       Impact factor: 2.472

9.  Genome sequence of Streptococcus agalactiae, a pathogen causing invasive neonatal disease.

Authors:  Philippe Glaser; Christophe Rusniok; Carmen Buchrieser; Fabien Chevalier; Lionel Frangeul; Tarek Msadek; Mohamed Zouine; Elisabeth Couvé; Lila Lalioui; Claire Poyart; Patrick Trieu-Cuot; Frank Kunst
Journal:  Mol Microbiol       Date:  2002-09       Impact factor: 3.501

10.  Preparation and properties of a protein (R antigen) occurring in streptococci of group A, type 28 and in certain streptococci of other serological groups.

Authors:  R C LANCEFIELD; G E PERLMANN
Journal:  J Exp Med       Date:  1952-07       Impact factor: 14.307

View more
  8 in total

1.  Immunological markers of the R4 protein of Streptococcus agalactiae.

Authors:  Johan A Maeland; Lars Bevanger; Randi Valsoe Lyng
Journal:  Clin Diagn Lab Immunol       Date:  2005-11

2.  Putative novel surface-exposed Streptococcus agalactiae protein frequently expressed by the group B streptococcus from Zimbabwe.

Authors:  Rooyen T Mavenyengwa; Johan A Maeland; Sylvester R Moyo
Journal:  Clin Vaccine Immunol       Date:  2009-07-08

3.  Streptococcus agalactiae alpha-like protein 1 possesses both cross-reacting and Alp1-specific epitopes.

Authors:  Augusta I Kvam; Rooyen T Mavenyengwa; Andreas Radtke; Johan A Maeland
Journal:  Clin Vaccine Immunol       Date:  2011-06-08

4.  Novel aspects of the Z and R3 antigens of Streptococcus agalactiae revealed by immunological testing.

Authors:  Johan A Maeland; Andreas Radtke; Randi V Lyng; Rooyen T Mavenyengwa
Journal:  Clin Vaccine Immunol       Date:  2013-02-13

Review 5.  Survey of immunological features of the alpha-like proteins of Streptococcus agalactiae.

Authors:  Johan A Maeland; Jan E Afset; Randi V Lyng; Andreas Radtke
Journal:  Clin Vaccine Immunol       Date:  2014-12-24

6.  Distinctive features of surface-anchored proteins of Streptococcus agalactiae strains from Zimbabwe revealed by PCR and dot blotting.

Authors:  Rooyen T Mavenyengwa; Johan A Maeland; Sylvester R Moyo
Journal:  Clin Vaccine Immunol       Date:  2008-07-30

7.  Whole-Genome Comparison Uncovers Genomic Mutations between Group B Streptococci Sampled from Infected Newborns and Their Mothers.

Authors:  Alexandre Almeida; Adrien Villain; Caroline Joubrel; Gérald Touak; Elisabeth Sauvage; Isabelle Rosinski-Chupin; Claire Poyart; Philippe Glaser
Journal:  J Bacteriol       Date:  2015-08-17       Impact factor: 3.490

8.  Recombinant group B Streptococcus alpha-like protein 3 is an effective immunogen and carrier protein.

Authors:  Hsiao-Hui Yang; Samantha J Mascuch; Lawrence C Madoff; Lawrence C Paoletti
Journal:  Clin Vaccine Immunol       Date:  2008-05-07
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.